A Phase I/II study of combination of TS-1, CDDP plus PTX in patients with advanced/recurrent gastric cancer (OGSG 0703)
Phase 1
- Conditions
- advanced/recurrent gastric cancer
- Registration Number
- JPRN-UMIN000002183
- Lead Sponsor
- OGSG
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
(1) with bleeding from digestive tract (2) patients who cannot take orally due to some stenosis on digestive tract (3) past history of severe allergy against some medicines (4) with high volume of ascites and/or thoratic fluid (5) with severe diseases (infection, interstitial pneumonitis, pulmonary fibrosis, cardiac failure, renal failure, liver disease, uncontrollable DM) (6) with liver cirrhosis and/or jaundice (7) with psychologic disorder which needs medicines (8) with brain disorder due to brain metastasis (9) with active second cancers. (10) women under pregnancy or women expecting future birth (11) doctors decision not to register to this trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method